AVADEL PHARMACEUTICALS PLC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Avadel Pharmaceuticals Plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2011 to Q3 2024.
  • Avadel Pharmaceuticals Plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 96.3M shares, a 7.74% increase year-over-year.
  • Avadel Pharmaceuticals Plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 80.2M shares, a 33.4% increase from 2022.
  • Avadel Pharmaceuticals Plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 60.1M shares, a 2.66% increase from 2021.
  • Avadel Pharmaceuticals Plc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 58.5M shares, a 6.54% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 96.3M +6.92M +7.74% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 96.2M +18.9M +24.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 91.7M +27.8M +43.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 80.2M +20.1M +33.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 89.4M +29.2M +48.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 77.2M +18.2M +30.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 63.9M +5.06M +8.61% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 60.1M +1.56M +2.66% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 60.2M +1.62M +2.76% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 59M +549K +0.94% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 58.8M +381K +0.65% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 58.5M +3.59M +6.54% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 58.6M +372K +0.64% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 58.5M -11.5M -16.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 58.4M +17.4M +42.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 54.9M +17.5M +46.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 58.2M +20.8M +55.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 69.9M +32.6M +87.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 41.1M +3.7M +9.91% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 37.4M +78K +0.21% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-16
Q3 2019 37.4M +532K +1.44% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 37.4M +584K +1.59% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 37.4M -1.21M -3.13% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 37.3M -4.44M -10.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-09
Q3 2018 36.9M -4.44M -10.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 36.8M -5.72M -13.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 38.6M -4.25M -9.93% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 41.8M +517K +1.25% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 41.3M +98K +0.24% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 42.5M +1.25M +3.02% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 42.8M +1.57M +3.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 41.2M -2.37M -5.44% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 41.2M +616K +1.52% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 41.2M +888K +2.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 41.2M -1.64M -3.82% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 43.6M +7.41M +20.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 40.6M +1.86M +4.79% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 40.4M +1.92M +4.98% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 42.9M +14.6M +51.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 36.2M +10.8M +42.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-28
Q3 2014 38.8M +13.3M +52.2% Jul 1, 2014 Sep 30, 2014 6-K 2014-11-17
Q2 2014 38.4M +38.4M Apr 1, 2014 Jun 30, 2014 6-K 2015-12-31
Q1 2014 28.3M +2.9M +11.4% Jan 1, 2014 Mar 31, 2014 6-K 2015-07-10
Q4 2013 25.5M +315K +1.25% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 25.5M +308K +1.22% Jul 1, 2013 Sep 30, 2013 6-K 2014-11-17
Q2 2013 25.4K* -25.1M Apr 1, 2013 Jun 30, 2013 6-K 2014-08-08
Q1 2013 25.4M +403K +1.61% Jan 1, 2013 Mar 31, 2013 6-K 2014-07-08
Q4 2012 25.1M Oct 1, 2012 Dec 31, 2012 20-F/A 2015-10-01
Q3 2012 25.2M Jul 1, 2012 Sep 30, 2012 6-K 2014-01-15
Q2 2012 25.2M +25.1M Apr 1, 2012 Jun 30, 2012 6-K 2013-12-06
Q1 2012 25M +366K +1.49% Jan 1, 2012 Mar 31, 2012 6-K 2012-09-13
Q2 2011 24.6K* Apr 1, 2011 Jun 30, 2011 6-K 2012-12-14
Q1 2011 24.6M Jan 1, 2011 Mar 31, 2011 6-K 2012-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.